Why AI Fails in Healthcare Clinics (And What Actually Works)
When clinics select an AI partner – especially for AI Voice Agents – the expectation…
Why AI Fails in Healthcare Clinics (And What Actually Works)
When clinics select an AI partner – especially for AI Voice Agents – the expectation is that the tool gets the job done. Without integration into your systems and workflows, that rarely happens. Clinics end up with an incomplete solution that never adds the expected value and fails at the exact use cases AI should…
Understanding Medicaid Cost Sharing and Policy Changes from the 2025 Reconciliation Law
This brief explains current Medicaid cost sharing rules and changes made to cost sharing rules by the 2025 reconciliation law, reports on cost sharing amounts states currently impose on ACA expansion adults, and highlights literature on the impact of cost sharing.
ICE Arrests Are Separating Families. Here’s How To Plan Ahead.
President Donald Trump’s immigration crackdown has parents who lack legal residency worried about the welfare of children left behind. Some jurisdictions are taking action. Maryland, Virginia, and Washington, D.C., allow families to name temporary guardians if a parent is detained or deported. KFF Health News correspondent Jazmin Orozco Rodriguez appeared on WAMU’s May 13 Health…
Colorado Charts Its Own Course on Vaccines Amid Federal Pullback
In response to abrupt and politicized changes to federal vaccine policy, concerned Coloradans have taken several steps to shore up support for vaccine science. A bill passed by the state legislature in March then signed into law by Democratic Gov. Jared Polis allows Colorado to further uncouple itself from federal guidance. The law allows health…
GHO Capital, CBC Group Combine to Form $21B Healthcare Investment Giant
London-based GHO Capital and Singapore-based CBC Group plan to merge in a deal that would create what the firms describe as the “world’s largest dedicated healthcare investment firm.” GHO has $10.5 billion assets under management, and CBC has $10.8 billion in assets under management. The post GHO Capital, CBC Group Combine to Form $21B Healthcare…
How long do Europeans have to wait for new pharmaceuticals after EMA approval?
The answer is provided by EFPIA’s annual WAIT indicator (press release, report). First, we see a large decrease in the share of pharmaceuticals fully availbity, drive by a small increase in reduced availability but a much larger increase in the number of drugs that only have a limited availability. Specifically, Historically full availability was the…
Report: How Employers Can Better Manage GLP-1s for Adolescents
A new Nomi Health report found that GLP-1 use and spending among adolescents rose sharply from 2022 to 2025, raising concerns about future costs for self-insured employers. The post Report: How Employers Can Better Manage GLP-1s for Adolescents appeared first on MedCity News.
Eli Lilly Grows Again in Genetic Medicines, Buying Startup With a New Way to Deliver DNA
Engage Bio developed a platform technology that enables non-viral delivery of DNA to cells. The acquisition is the latest in a series of Eli Lilly deals that expand the pharmaceutical company’s pipeline and capabilities in genetic medicines. The post Eli Lilly Grows Again in Genetic Medicines, Buying Startup With a New Way to Deliver DNA…
MedCity Pivot Podcast: A Conversation About Interoperability with Particle Health’s CEO
Jason Prestinario talks about the state of healthcare interoperability today, while also addressing questions about the interoperability lawsuits he and others are involved in against Epic. The post MedCity Pivot Podcast: A Conversation About Interoperability with Particle Health’s CEO appeared first on MedCity News.
Assessing PEPFAR’s Health Spillover Effects Beyond HIV: An Update
This analysis updates prior work that assessed the association between PEPFAR investments and several health indicators, beyond HIV. It finds that PEPFAR continues to be associated with significant improvement in these broader health gains, suggesting a spillover effect beyond the program’s HIV focus.
